Sequencing Encephalopathy: Do not be Fooled by Documentation of “due to.”

Sequencing Encephalopathy: Do not be Fooled by Documentation of “due to.”

Someone recently asked on LinkedIn if they must always sequent a UTI as the principal diagnosis when encephalopathy due to a urinary tract infection (UTI) is documented.

I disagree with this advice and here is why:

Coding Conventions and Guidelines

As discussed in the first article in this series, it is not necessary to link metabolic encephalopathy to the underlying infection e.g., the UTI. When this documentation occurs, some may overgeneralize the assignment of the principal diagnosis coding guideline that the condition after study is sequenced as the principal diagnosis. However, we cannot ignore other applicable coding conventions and guidelines. General Coding Guidelines 2.4 Signs and Symptoms states,

Codes that describe symptoms and signs, as opposed to diagnoses, are acceptable for reporting purposes when a related definitive diagnosis has not been established (confirmed) by the provider. Chapter 18 of ICD-10-CM, Symptoms, Signs, and Abnormal Clinical and Laboratory Findings, Not Elsewhere Classified (codes R00.0 – R99) contains many, but not all, codes for symptoms p. 13).

Guideline 2.18 Use of Signs/Symptoms/Unspecified Codes states,

“While specific diagnosis codes should be reported when they are supported by the available medical record documentation and clinical knowledge of the patient’s health condition, there are instances when signs/symptoms or unspecified codes are the best choices for accurately reflecting the healthcare encounter. Each healthcare encounter should be coded to the level of certainty known for that encounter. . . If a definitive diagnosis has not been established by the end of the encounter, it is appropriate to report codes for sign(s) and/or symptom(s) in lieu of a definitive diagnosis p. 17).”

Chapter Specific Guideline C.18 Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99) states this chapter includes symptoms, signs, etc., regarding which no diagnosis classifiable elsewhere is recorded. It also reiterates that symptoms codes, “are acceptable for reporting purposes when a definitive diagnosis has not been established (confirmed) by the provider p. 75).

Reporting a Definitive Diagnosis

Providers will often document that a patient is being admitted for altered mental status (AMS, code R41.82), which is a symptom code. Based on the above-mentioned guidelines, CDI professionals should look for evidence in the health record for a definitive diagnosis associated with altered mental status, which as discussed in prior articles is likely to be metabolic encephalopathy, toxic encephalopathy, or acute delirium.

Encephalopathy is a definitive diagnosis that is always due to another condition.

Assigning the Principal Diagnosis

But should acute (metabolic or toxic) encephalopathy be the principal diagnosis? If the associated diagnosis is metabolic encephalopathy, my opinion is yes. But the sequencing of toxic encephalopathy is more complicated.

Coding conventions (contained within Section 1 of the ICD-10-CM Official Guidelines for Coding and Reporting), which include instructional notes, supersede coding guidelines including assignment of the principal diagnosis. Although most coding is performed electronically, compliant coding requires consulting the alphabetic index and the tabular list before assigning a code. The tabular list includes instructional notes that are necessary for accurate code assignment.

The entry for encephalopathy in the alphabetic index includes an option for metabolic, which leads to G93.41 in the tabular list. Under metabolic, there are entries for drug induced and toxic, both of which take you to G92.8 in the tabular list.

  • At the category level, G93 Other disorders of brain, there are no general instructional notes.
  • The subcategory of G93.4 includes metabolic encephalopathy as well as encephalopathy, unspecified and other encephalopathy. At this level there is an Exclude2 note, which means the condition can also be coded, if appropriate.
  • Regarding metabolic encephalopathy (G93.41), there are no instructional notes or other general or chapter specific instructions related to sequencing.

In contrast, when coding toxic encephalopathy the sequencing of toxic encephalopathy due to drugs is based on whether the drug toxicity qualifies as an adverse effect or poisoning.

  • When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug (T36–T50). The code for the drug will have a fifth or sixth character 5 (e.g., T36.0x5-) to indicate adverse effect. There is an “use additional code” note at both other toxic encephalopathy (G92.8) and unspecified toxic encephalopathy (G92.9).
  • If the toxic encephalopathy is due to a poisoning from a toxic agent, a code from categories T51–T65 is assigned first to identify the causative toxic agent. A code first note is at both of the toxic encephalopathy codes.

Therefore, when it comes to reporting toxic encephalopathy if it is due to poisoning it will not be the principal diagnosis. If it is due to an adverse effect, it may be the principal diagnosis if it meets the definition for reporting.

Sequencing Metabolic Encephalopathy due to a UTI

But my focus for this article is sequencing metabolic encephalopathy due to a UTI. If we look at code N39.0 for UTI, site not specified in the tabular list, we see an instructional note to use additional code to identify the infectious agent. There is also an Excludes1 note (do not code together) that does not include AMS, delirium, or encephalopathy.

Since there are no coding conventions that apply to the sequencing of these two diagnoses, let us look at the definition of a principal diagnosis and its associated guidelines. The Uniform Hospital Discharge Data Set (UHDDS) defines it as the “condition established after study to be chiefly responsible for occasioning the admission of the patient to the hospital for care (p. 107).”

In my opinion if the physician states the reason for the admission is AMS, which is clarified as metabolic encephalopathy, then metabolic encephalopathy should be the principal diagnosis regardless of the cause.

What if the provider does not clearly indicate the reason for the admission? Some CDI and coding professionals will apply guideline II.C Two or more diagnoses that equally meet the definition for principal diagnosis, which states,

“In the unusual instance when two or more diagnoses equally meet the criteria for principal diagnosis as determined by the circumstances of admission, diagnostic workup and/or therapy provided, and the Alphabetic Index, Tabular List, or another coding guidelines does not provide sequencing direction, any one of the diagnoses may be sequenced first (p. 108).”

Even if the provider does not specifically state the patient is admitted for AMS, UTIs do not usually require inpatient admission. It should be rare that a UTI is the reason for an inpatient admission. More often than not, UTI is an incidental finding but was not the primary focus of the workup even though it receives treatment. The UTI must be treated to address the associated metabolic encephalopathy. Additionally, documentation of metabolic encephalopathy due to UTI is irrelevant to the sequencing since there are no applicable instructional notes at either diagnosis or is it required by the definition of the principal diagnosis which talks about the condition after study. The condition that was studied was AMS, a symptom, and it was clarified into the definitive diagnosis of metabolic encephalopathy.

It is also important to note that the AHA Coding Clinic specifically addressed how to sequence encephalopathy due to UTI in the 2nd Qtr. 2018 (p. 22) that the sequencing is based on the condition found after study to be responsible for the hospital admission. A trick I used to help identify the principal diagnosis is by asking what condition must be resolved prior to discharge. Will a patient be sent home with a UTI? Yes. Will a patient be sent home with acute metabolic encephalopathy? No. Therefore, clinically, the reason for the admission is the metabolic encephalopathy.

Why this sequencing is so confusing is that encephalopathy is a diagnosis made through the process of elimination. This is why a head CT is often performed on patients who present with acute AMS, to determine if it could be related to a structural cause that will appear on imaging like a stroke. A head CT is not indicated for a UTI, nor is an EEG, if performed, or any of the other diagnostic tests used to determine the cause of AMS. If the metabolic encephalopathy is secondary to the UTI, it should improve after a period of antibiotics. Again, the point at which the patient is usually discharged is when the patient’s metal status returns to baseline, not with the UTI is resolved.

My best advice for those who have an inpatient claim with metabolic encephalopathy due to UTI is to look for evidence of sepsis as this diagnosis will support an inpatient admission for a UTI. It would also likely be sequenced as the principal diagnosis assuming it is present on admission, which solves the sequencing issue.

Facebook
Twitter
LinkedIn

Cheryl Ericson, RN, MS, CCDS, CDIP

Cheryl is the Senior Director of Clinical Policy and Education, Brundage Group. She is an experienced revenue cycle expert and is known internationally for her work as a CDI professional. Cheryl has helped establish industry guidance through contributions to ACDIS white papers and several AHIMA Practice Briefs in the areas of CDI, Denials, Quality, Querying and HIM Technology.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Sepsis: Bridging the Clinical Documentation and Coding Gap to Reduce Denials

Sepsis: Bridging the Clinical Documentation and Coding Gap to Reduce Denials

Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.

September 24, 2025
2026 IPPS Masterclass 3: Master MS-DRG Shifts and NTAPs

2026 IPPS Masterclass Day 3: MS-DRG Shifts and NTAPs

This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 14, 2025
2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 13, 2025

Trending News

Featured Webcasts

Surviving Federal Audits for Inpatient Rehab Facility Services

Surviving Federal Audits for Inpatient Rehab Facility Services

Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.

November 13, 2025
E/M Services Under Intensive Federal Scrutiny: Navigating Split/Shared, Incident-to & Critical Care Compliance in 2025-2026

E/M Services Under Intensive Federal Scrutiny: Navigating Split/Shared, Incident-to & Critical Care Compliance in 2025-2026

During this essential RACmonitor webcast Michael Calahan, PA, MBA Certified Compliance Officer, will clarify the rules, dispel common misconceptions, and equip you with practical strategies to code, document, and bill high-risk split/shared, incident-to & critical care E/M services with confidence. Don’t let audit risks or revenue losses catch your organization off guard — learn exactly what federal auditors are looking for and how to ensure your documentation and reporting stand up to scrutiny.

August 26, 2025
The Two-Midnight Rule: New Challenges, Proven Strategies

The Two-Midnight Rule: New Challenges, Proven Strategies

RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.

June 19, 2025

Trending News

Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more

Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24